Audit of adherence to National Institute of Clinical Excellence guidelines for the use of drotrecogin alfa (activated)

被引：0
|
作者：
R Vedantham
B Iyowu
机构：
[1] University Hospital Lewisham,
来源：
Critical Care | / 11卷 / Suppl 2期
关键词：
Standardise Mortality Ratio; Clinical Excellence; Base Deficit; Drotrecogin Alfa; Patient Selection Criterion;
D O I：
10.1186/cc5219
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Drotrecogin alfa (activated): diffusion from clinical trials to clinical practice
    Ridley, S.
    Lwin, A.
    Wyncoll, D.
    Lippett, S.
    Watson, D.
    Gunning, K.
    Higgins, D.
    [J]. EUROPEAN JOURNAL OF ANAESTHESIOLOGY, 2008, 25 (03) : 211 - 216
  • [22] An audit of practice against National Institute of Clinical Excellence (NICE) guidelines for the diagnosis and management of Parkinson's disease (PD)
    Dobson, R.
    Bindman, D.
    Lindahl, A. J.
    [J]. MOVEMENT DISORDERS, 2009, 24 : S366 - S367
  • [23] Drotrecogin alfa (activated): diffusion from clinical trials to clinical practice
    Mackenzie, A. F.
    [J]. EUROPEAN JOURNAL OF ANAESTHESIOLOGY, 2008, 25 (10) : 861 - 862
  • [24] Use of drotrecogin alfa activated in septic AIDS patients.
    Rowden, AM
    [J]. PHARMACOTHERAPY, 2004, 24 (10): : 1429 - 1429
  • [25] Drotrecogin alfa (activated): From bench to practical use at the bedside
    Rodriguez, J
    [J]. AMERICAN JOURNAL OF SURGERY, 2002, 184 (6A): : 1S - 2S
  • [26] Clinical response to unintentionally rapid infusion of drotrecogin alfa (activated)
    Urban, Theresa M.
    Mitchell, George A.
    Wellborn-Kim, Jennifer J.
    Terneus, William F., Jr.
    Callahan, Charles M.
    Mendes, Joseph
    Webber, Shannon L.
    [J]. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2010, 67 (14) : 1174 - 1177
  • [27] Effectiveness of drotrecogin alfa (activated) in clinical practice: A stitch in time
    Doig, Gordon
    [J]. CRITICAL CARE MEDICINE, 2008, 36 (01) : 332 - 333
  • [28] Use of drotrecogin alfa (activated) in older patients with severe sepsis
    Alexander, SL
    Ernst, FR
    [J]. PHARMACOTHERAPY, 2006, 26 (04): : 533 - 538
  • [29] Impact of drotrecogin alfa (activated) on resource use and implications for reimbursement
    Dasta, JF
    Cooper, LM
    [J]. PHARMACOTHERAPY, 2002, 22 (12): : 216S - 222S
  • [30] Adherence to the new National Institute for Clinical Excellence (NICE) quality standards for Anaphylaxis
    Fenton, S.
    Perkin, M.
    Bidgood, S.
    Christopher, A.
    Vaughan, S.
    Thomas, L.
    [J]. CLINICAL AND EXPERIMENTAL ALLERGY, 2016, 46 (12): : 1653 - 1653
12345